Pages

Wednesday, February 24, 2021

Tie-up with Serum Institute of India key to mass production of COVID vaccines, say two pharma majors

Covishield is less expensive compared to some of the other vaccines being used — such as the ones from Pfizer-BioNTech and Moderna.

from The Hindu - National https://ift.tt/37GjPGn
via alochona

No comments:

Post a Comment